Literature DB >> 12467885

Molecules interacting with PRIP-2, a novel Ins(1,4,5)P3 binding protein type 2: Comparison with PRIP-1.

Ayako Uji1, Miho Matsuda, Toshio Kukita, Katsumasa Maeda, Takashi Kanematsu, Masato Hirata.   

Abstract

A family of phospholipase C-related, catalytically inactive proteins (designated PRIP) have been identified as a group of novel inositol 1,4,5-trisphosphate binding proteins with a domain organization similar to phospholipase C-delta but lacking the enzymatic activity. The PRIP family consists of at least two types of proteins (PRIP-1 and PRIP-2 subfamilies). In the present study, we examined the tissue distribution of PRIP-2, its expression in rat brain at the mRNA level, and the characteristics of its binding to inositol compounds, protein phosphatase 1, and gamma-amino butyric acid receptor associated protein. We also compared these characteristics with those of PRIP-1. Northern blot analysis and reverse-transcription polymerase chain reaction showed that PRIP-1 was present mainly in the brain, whereas PRIP-2 was expressed ubiquitously. In situ hybridization studies using rat brain revealed that the mRNA for both PRIP-1 and PRIP-2 was similarly expressed; it was detected in the granular cell and Purkinje cell layers in the cerebellum, and in the hippocampal pyramidal cells, dentate granule cells, and pyramidal and/or granule cells of the cerebral cortex in the cerebrum. PRIP-2 bound inositol 1,4,5-trisphosphate and its parent lipid, phosphatidylinositol 4,5-bisphosphate, with a similar affinity, while PRIP-1 preferentially bound the former ligand by about 10-fold. PRIP-1 and PRIP-2 interacted with protein phosphatase 1 and gamma-amino butyric acid receptor associated protein in a similar manner. These results indicate that, similar to PRIP-1, PRIP-2 may be involved in both inositol 1,4,5-trisphosphate-mediated and gamma-amino butyric acid-related signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467885     DOI: 10.1016/s0024-3205(02)02275-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

1.  New insights into the families of PLC enzymes: looking back and going forward.

Authors:  Matilda Katan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

2.  Phospholipase C-related but catalytically inactive protein (PRIP) modulates synaptosomal-associated protein 25 (SNAP-25) phosphorylation and exocytosis.

Authors:  Jing Gao; Hiroshi Takeuchi; Zhao Zhang; Mitsunori Fukuda; Masato Hirata
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

3.  Involvement of PRIP, phospholipase C-related, but catalytically inactive protein, in bone formation.

Authors:  Koshiro Tsutsumi; Miho Matsuda; Miho Kotani; Akiko Mizokami; Ayako Murakami; Ichiro Takahashi; Yoshihiro Terada; Takashi Kanematsu; Kiyoko Fukami; Tadaomi Takenawa; Eijiro Jimi; Masato Hirata
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

Review 4.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

Review 5.  GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition.

Authors:  Tija C Jacob; Stephen J Moss; Rachel Jurd
Journal:  Nat Rev Neurosci       Date:  2008-05       Impact factor: 34.870

Review 6.  GABAA receptor trafficking-mediated plasticity of inhibitory synapses.

Authors:  Bernhard Luscher; Thomas Fuchs; Casey L Kilpatrick
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

Review 7.  Phosphorylation of GABAA receptors influences receptor trafficking and neurosteroid actions.

Authors:  Eydith Comenencia-Ortiz; Stephen J Moss; Paul A Davies
Journal:  Psychopharmacology (Berl)       Date:  2014-05-22       Impact factor: 4.530

8.  Phospholipase C-related but catalytically inactive proteins regulate ovarian follicle development.

Authors:  Miho Matsuda; Masato Hirata
Journal:  J Biol Chem       Date:  2017-03-30       Impact factor: 5.157

9.  Contractile agonists attenuate cGMP levels by stimulating phosphorylation of cGMP-specific PDE5; an effect mediated by RhoA/PKC-dependent inhibition of protein phosphatase 1.

Authors:  K S Murthy
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

10.  PRIP (phospholipase C-related but catalytically inactive protein) inhibits exocytosis by direct interactions with syntaxin 1 and SNAP-25 through its C2 domain.

Authors:  Zhao Zhang; Hiroshi Takeuchi; Jing Gao; DaGuang Wang; Declan J James; Thomas F J Martin; Masato Hirata
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.